BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.96B |
| 2 |
Coupang
CPNG
|
+$1.77B |
| 3 |
Amazon
AMZN
|
+$1.55B |
| 4 |
International Flavors & Fragrances
IFF
|
+$1.19B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$1.46B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.39B |
| 3 |
DuPont de Nemours
DD
|
+$948M |
| 4 |
Alibaba
BABA
|
+$860M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$852M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.79% |
| 2 | Healthcare | 13.36% |
| 3 | Financials | 12.86% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Aquestive Therapeutics
AQST
$553M
| $7.05M | ﹤0.01% |
1,356,400
+50,562
| +4% | +$269K |
|
3727
Arq
ARQ
$99.1M
| $7.04M | ﹤0.01% |
1,280,627
+70,267
| +6% | +$394K |
|
|
FUV
3728
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $7.04M | ﹤0.01% |
26,607
-156
| -0.6% | -$62.2K |
|
3729
Fennec Pharmaceuticals
FENC
$448M
| $7.04M | ﹤0.01% |
1,132,769
+25,565
| +2% | +$192K |
|
3730
Arbutus Biopharma
ABUS
$923M
| $6.99M | ﹤0.01% |
2,097,710
+276,603
| +15% | +$1.07M |
|
3731
Aviat Networks
AVNW
$272M
| $6.98M | ﹤0.01% |
196,592
-39,976
| -17% | -$1.05M |
|
3732
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
| $6.97M | ﹤0.01% |
54,275
-2,900
| -5% | -$367K |
|
|
FSFG
3733
DELISTED
First Savings Financial Group
FSFG
| $6.96M | ﹤0.01% |
310,923
+26,868
| +9% | +$577K |
|
3734
SB Financial Group
SBFG
$170M
| $6.96M | ﹤0.01% |
399,925
+35,256
| +10% | +$619K |
|
|
LFC
3735
DELISTED
China Life Insurance Company Ltd.
LFC
| $6.94M | ﹤0.01% |
666,629
+666,329
| +222,110% | +$7.21M |
|
3736
Schwab US TIPS ETF
SCHP
$16.2B
| $6.93M | ﹤0.01% |
226,682
+108,612
| +92% | +$3.35M |
|
3737
Ericsson
ERIC
$33B
| $6.92M | ﹤0.01% |
524,999
+524,412
| +89,338% | +$6.68M |
|
|
MBCN
3738
DELISTED
Middlefield Banc Corp
MBCN
| $6.89M | ﹤0.01% |
328,867
+39,413
| +14% | +$876K |
|
|
PBIP
3739
DELISTED
Prudential Bancorp, Inc.
PBIP
| $6.87M | ﹤0.01% |
465,367
+23,079
| +5% | +$310K |
|
|
NBSE
3740
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $6.87M | ﹤0.01% |
46,470
+8
| +0% | +$1.45K |
|
3741
Ebang International Holdings
EBON
$13.2M
| $6.83M | ﹤0.01% |
28,625
+23,922
| +509% | +$5.12M |
|
3742
NACCO Industries
NC
$306M
| $6.81M | ﹤0.01% |
273,111
+4,392
| +2% | +$107K |
|
3743
Minerva Neurosciences
NERV
$206M
| $6.81M | ﹤0.01% |
291,671
+15,272
| +6% | +$382K |
|
3744
Rogers Communications
RCI
$19.1B
| $6.79M | ﹤0.01% |
147,293
+133,818
| +993% | +$6.26M |
|
3745
ClearPoint Neuro
CLPT
$455M
| $6.77M | ﹤0.01% |
320,087
+272,022
| +566% | +$5.82M |
|
3746
Asure Software
ASUR
$243M
| $6.76M | ﹤0.01% |
884,615
+116,524
| +15% | +$933K |
|
3747
Mayville Engineering Co
MEC
$574M
| $6.71M | ﹤0.01% |
466,514
+13,935
| +3% | +$205K |
|
3748
Aterian
ATER
$5.32M
| $6.69M | ﹤0.01% |
18,907
+16,518
| +691% | +$6.36M |
|
3749
Tango Therapeutics
TNGX
$4.44B
| $6.67M | ﹤0.01% |
600,000
| – | – |
|
3750
Maui Land & Pineapple Co
MLP
$319M
| $6.62M | ﹤0.01% |
573,210
+14,292
| +3% | +$168K |
|
Similar funds
BlackRock's Q1 2021 Portfolio in Review
As of Q1 2021, BlackRock held 5,453 positions worth $3.4T, up 8.5% from $3.13T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BlackRock's Q1 2021 filing shows 377 new, 3,642 increased, 849 reduced and 151 closed positions. Its largest new stake was Coupang: 38,242,925 shares worth $1.89B. The largest sale was Tiffany & Co., an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2021 buy was Coupang: 38,242,925 shares worth $1.89B.
- BlackRock added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $4.96B increase.
- BlackRock's biggest Q1 2021 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.39B.
- BlackRock fully exited Tiffany & Co. in Q1 2021, selling an estimated $1.46B.
- BlackRock's ten largest holdings make up 17% of its $3.4T portfolio in Q1 2021.
- BlackRock opened 377 new positions and closed 151 in Q1 2021.
- BlackRock's portfolio value rose 8.5% quarter-over-quarter to $3.4T.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.